Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATG vs ATG + PTCy for GVHD Prophylaxis
NCT04202835Phase 2Active, not recruiting
- Sponsor
- McMaster University
- Start
- Oct 2020
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of cyclophosphamide in chronic graft-versus-host disease (cGVHD), sponsored by McMaster University. Started Oct 2020; status: active, not recruiting.
02
Drugs
cyclophosphamide
03
Conditions
chronic graft-versus-host disease (cGVHD)
Beyond the preview
Go deeper on NCT04202835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04202835.